Literature DB >> 3876099

Impaired B cell proliferation by Staphylococcus aureus Cowan 1 in patients with systemic lupus erythematosus.

S Sawada, S Amaki, M Takei, M Karasaki, I Amaki.   

Abstract

We examined the proliferative response to Staphylococcus aureus Cowan 1 (SAC) by enriched peripheral blood B cells from patients with systemic lupus erythematosus (SLE). Responses of B cells from patients with active and inactive SLE were significantly lower than those of B cells from normal individuals. Hyporesponsiveness to SAC was not observed in healthy family members of SLE patients. This hyporesponsiveness did not correlate with prednisolone therapy and could not be attributed to serum factors; it did correlate with the presence of suppressor monocytes. However, we could not exclude the possibility of enhanced sensitivity of SLE B lymphocytes to suppressive signals delivered by the monocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876099     DOI: 10.1002/art.1780280908

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Polyclonal B cell activation in ankylosing spondylitis.

Authors:  P Barbieri; I Olivieri; G Benedettini; P Marelli; M L Ciompi; G Pasero; M Campa
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

2.  B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus.

Authors:  H Becker; U Schauer; K Helmke
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

3.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

4.  Functional T cell subpopulations responsible for hyposecretion of IL-2 in patients with systemic lupus erythematosus.

Authors:  T Hayama; N Kubo; E Ikeda; H Hashimoto; S Sawada; T Horie
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

5.  Human immunoglobulin production in immunodeficient mice: enhancement by immunosuppression of host and in vitro activation of human mononuclear cells.

Authors:  L A Cavacini; M Kennel; E V Lally; M R Posner; A Quinn
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.

Authors:  M Murakami; S Kumagai; M Sugita; K Iwai; H Imura
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

7.  Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE).

Authors:  K Mitamura; H Kang; Y Tomita; H Hashimoto; S Sawada; T Horie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

8.  Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus.

Authors:  N Suzuki; T Sakane
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.